Evidence map›Paper›PMID 23665676›Full record

ArticleOncogene2014

Tumor-derived mural-like cells coordinate with endothelial cells: role of YKL-40 in mural cell-mediated angiogenesis.

R Francescone, N Ngernyuang, W Yan, B Bentley, R Shao

Abstract read
In one paragraph

Article in Oncogene, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. In Vitro Models to Study Angiogenesis and Vasculature.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  7. In Vitro Tube Formation Assays in Matrigel.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  8. Article
  9. Article
  10. Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin.Journal of experimental & clinical cancer research : CR · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

R FrancesconeMolecular and Cellular Biology Program, Morrill Science Center, University of Massachusetts, Amherst, MA, USA.
N NgernyuangGraduate School, Khon Khaen University, Khon Khaen, Thailand.
W YanPioneer Valley Life Sciences Institute, Springfield, MA, USA.
B BentleyPioneer Valley Life Sciences Institute, Springfield, MA, USA.
R Shao1] Molecular and Cellular Biology Program, Morrill Science Center, University of Massachusetts, Amherst, MA, USA [2] Pioneer Valley Life Sciences Institute, Springfield, MA, USA [3] Department of Veterinary and Animal Sciences, University of Massachusetts, Amherst, MA, USA.

Funding

Role of a novel angiogenic factor, YKL-40, in breast cancer progressionR01CA120659 · NCI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI SHAO, RONG · 2008 to 2012
$1.1M
NCI NIH HHS R01 CA120659
6 · The paper itself

Abstract

Tumor neo-vasculature is characterized by spatial coordination of endothelial cells with mural cells, which delivers oxygen and nutrients. Here, we explored a key role of the secreted glycoprotein YKL-40, a mesenchymal marker, in the interaction between endothelial cells and mesenchymal mural-like cells for tumor angiogenesis. Xenotransplantation of tumor-derived mural-like cells (GSDCs) expressing YKL-40 in mice developed extensive and stable blood vessels covered with more GSDCs than those in YKL-40 gene knockdown tumors. YKL-40 expressed by GSDCs was associated with increased interaction of neural cadherin/β-catenin/smooth muscle alpha actin; thus, mediating cell-cell adhesion and permeability. YKL-40 also induced the interaction of vascular endothelial cadherin/β-catenin/actin in endothelial cells (HMVECs). In cell co-culture systems, YKL-40 enhanced both GSDC and HMVEC contacts, restricted vascular leakage, and stabilized vascular networks. Collectively, the data inform new mechanistic insights into the cooperation of mural cells with endothelial cells induced by YKL-40 during tumor angiogenesis, and also enhance our understanding of YKL-40 in both mural and endothelial cell biology.

Indexed as

ActinsAdipokinesAnimalsbeta CateninBlotting, WesternCadherinsCell AdhesionCell Membrane PermeabilityCells, CulturedChitinase-3-Like Protein 1Coculture TechniquesEndothelial CellsHumansImmunohistochemistryLectinsMiceActinsAdipokinesbeta CateninCadherinsCHI3L1 protein, humanChitinase-3-Like Protein 1LectinsPlatelet Endothelial Cell Adhesion Molecule-1

Identifiers

PMID23665676
PMCPMC3926897

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.